{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:46:34Z","timestamp":1753875994198,"version":"3.41.2"},"reference-count":53,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Experimental studies have shown fibroblast growth factor 23 (FGF23)-mediated upregulation of the distal tubule sodium\/chloride (Na+Cl\u2212) co-transporter leading to increased Na reabsorption, volume expansion and hypertension. However, data on the associations of FGF23 with renal Na regulation and blood pressure (BP) are lacking in young CKD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>FGF23 and other determinants of mineral metabolism, plasma renin activity (PRA), fractional excretion of Na (FENa) and BP, were analyzed at a single center in 60 patients aged 5\u201322\u2009years with CKD Stages 1 (n\u2009=\u200933) and Stages 2\u20133 (n\u2009=\u200927) defined by cystatin C- and creatinine-based estimating equations (estimated glomerular filtration rate, eGFR). Associations between FGF23 and renal Na handling were explored by regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median FGF23 levels were higher in CKD Stages 2\u20133 versus CKD 1 (119 versus 79 RU\/mL; P\u2009&lt;\u20090.05), with hyperparathyroidism [parathyroid hormone (PTH) &gt;69\u2009pg\/mL] in only few subjects with CKD Stages 2\u20133. Median FENa was comparable in both subgroups, but with proportionally more values above the reference mean (0.55%) in CKD Stages 2\u20133 and 3-fold higher (1.6%) in CKD Stage 3. PRA was higher in CKD Stages 2\u20133 (P\u2009&lt;\u20090.05). Meanwhile in CKD Stage 1, FGF23 did not associate with FENa, and in CKD Stages 2\u20133 FGF23 associated positively with FENa (r\u2009=\u20090.4; P\u2009&lt;\u20090.05) and PTH (r\u2009=\u20090.45; P\u2009&lt;\u20090.05), and FENa associated with FE of phosphate (r\u2009=\u20090.6; P\u2009&lt;\u20090.005). Neither FGF23 nor FENa was associated with systolic or diastolic BP in either subgroup. The negative association of eGFR by cystatin with FENa remained the strongest predictor of FENa by multivariable linear regression in CKD Stages 2\u20133.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The elevated FGF23, FENa and PRA and the positive association of FGF23 with FENa do not suggest FGF23-mediated increased tubular Na reabsorption and volume expansion as causing hypertension in young patients with incipient CKD.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ckj\/sfz081","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T11:09:07Z","timestamp":1559214547000},"source":"Crossref","is-referenced-by-count":1,"title":["Fibroblast growth factor 23 and tubular sodium handling in young patients with incipient chronic kidney disease"],"prefix":"10.1093","author":[{"given":"Michael","family":"Freundlich","sequence":"first","affiliation":[{"name":"Division of Pediatric Nephrology, Jackson Memorial-Holtz Children\u2019s Hospital, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cuervo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Jackson Memorial-Holtz Children\u2019s Hospital, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn L","family":"Abitbol","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Jackson Memorial-Holtz Children\u2019s Hospital, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"2019070401125069200_sfz081-B1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2019070401125069200_sfz081-B2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2011111115","article-title":"Cardiovascular disease in children with chronic kidney disease","volume":"23","author":"Mitsnefes","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"2019070401125069200_sfz081-B4","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","article-title":"Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"14","author":"Mitsnefes","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B5","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2019070401125069200_sfz081-B6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"2019070401125069200_sfz081-B7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2019070401125069200_sfz081-B8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.02110217","article-title":"FGF23 and left ventricular hypertrophy in children with CKD","volume":"13","author":"Mitsnefes","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B9","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"2019070401125069200_sfz081-B10","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1038\/s41598-018-30098-1","article-title":"Cardiovascular interactions between fibroblast growth factor-23 and angiotensin II","volume":"8","author":"Pi","year":"2018","journal-title":"Sci Rep"},{"key":"2019070401125069200_sfz081-B11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HJH.0000000000000936","article-title":"Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"34","author":"Fyfe-Johnson","year":"2016","journal-title":"J Hypertens"},{"key":"2019070401125069200_sfz081-B12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.kint.2018.02.017","article-title":"The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk","volume":"94","author":"Pastor-Arroyo","year":"2018","journal-title":"Kidney Int"},{"key":"2019070401125069200_sfz081-B13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2019070401125069200_sfz081-B14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI105748","article-title":"Studies on the characteristics of the control system governing sodium excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J Clin Invest"},{"key":"2019070401125069200_sfz081-B15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9343(82)90523-X","article-title":"Disorders of body fluids, sodium and potassium in chronic renal failure","volume":"72","author":"Mitch","year":"1982","journal-title":"Am J Med"},{"key":"2019070401125069200_sfz081-B16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.HYP.7.5.714","article-title":"Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake","volume":"7","author":"Koomans","year":"1985","journal-title":"Hypertension"},{"key":"2019070401125069200_sfz081-B17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jash.2012.07.004","article-title":"Thiazide diuretics in advanced chronic kidney disease","volume":"6","author":"Agarwal","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"2019070401125069200_sfz081-B18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11906-014-0525-x","article-title":"Thiazide diuretics in chronic kidney disease","volume":"17","author":"Sinha","year":"2015","journal-title":"Curr Hypertens Rep"},{"author":"Srivastava","key":"2019070401125069200_sfz081-B19"},{"key":"2019070401125069200_sfz081-B20","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfy315","article-title":"Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease","author":"Xu","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2019070401125069200_sfz081-B21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"2019070401125069200_sfz081-B22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00467-016-3356-y","article-title":"Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I","volume":"31","author":"Cuervo","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"2019070401125069200_sfz081-B23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000184216","article-title":"Direct measurement of TP\/GFR: a simple and reliable parameter of renal phosphate handling","volume":"44","author":"Stark","year":"1986","journal-title":"Nephron"},{"key":"2019070401125069200_sfz081-B24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2019070401125069200_sfz081-B25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2019070401125069200_sfz081-B26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.05840513","article-title":"Disordered FGF23 and mineral metabolism in children with CKD","volume":"9","author":"Portale","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B27","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI105877","article-title":"Control of phosphate excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J Clin Invest"},{"key":"2019070401125069200_sfz081-B28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ki.2013.198","article-title":"Dietary phosphate: the challenges of exploring its role in FGF23 regulation","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"2019070401125069200_sfz081-B29","first-page":"1862","volume-title":"The Kidney","author":"Meyer","year":"1991"},{"key":"2019070401125069200_sfz081-B30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2014.12.012","article-title":"Regulation of blood pressure and renal function by NCC and ENaC: lessons from genetically engineered mice","volume":"21","author":"Verouti","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"2019070401125069200_sfz081-B31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(72)90054-X","article-title":"Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease","volume":"5","author":"Laragh","year":"1972","journal-title":"Am J Med"},{"key":"2019070401125069200_sfz081-B32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.V102323","article-title":"Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease","volume":"10","author":"Vande Walle","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MNH.0b013e3282f5244e","article-title":"Cotransporters, WNKs and hypertension: an update","volume":"17","author":"Flatman","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2019070401125069200_sfz081-B34","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/HJH.0b013e32834bbc8a","article-title":"Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort","volume":"29","author":"Sim","year":"2011","journal-title":"J Hypertens"},{"key":"2019070401125069200_sfz081-B35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000169046","article-title":"Inappropriately high plasma renin activity accompanies chronic loss of renal function","volume":"16","author":"Yeyati","year":"1996","journal-title":"Am J Nephrol"},{"key":"2019070401125069200_sfz081-B36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2012.03.061","article-title":"Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease","volume":"167","author":"Poletti","year":"2013","journal-title":"Int J Cardiol"},{"key":"2019070401125069200_sfz081-B37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2017.10.010","article-title":"Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure","volume":"253","author":"Ter Maaten","year":"2018","journal-title":"Int J Cardiol"},{"key":"2019070401125069200_sfz081-B38","doi-asserted-by":"crossref","first-page":"F1168","DOI":"10.1152\/ajprenal.00606.2015","article-title":"FGF23 from bench to bedside","volume":"310","author":"Kovesdy","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019070401125069200_sfz081-B39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpy154","article-title":"Cardioprotective effects of paricalcitol alone and in combination with FGF23 receptor inhibition in chronic renal failure: experimental and clinical studies","volume":"32","author":"Czaya","year":"2019","journal-title":"Am J Hypertens"},{"key":"2019070401125069200_sfz081-B40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2019070401125069200_sfz081-B41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"2019070401125069200_sfz081-B42","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"de Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","article-title":"Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study","volume":"52","author":"Flynn","year":"2008","journal-title":"Hypertension"},{"key":"2019070401125069200_sfz081-B44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.2005030276","article-title":"Left ventricular geometry in children with mild to moderate chronic renal insufficiency","volume":"17","author":"Matteucci","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2009060609","article-title":"Masked hypertension associates with left ventricular hypertrophy in children with CKD","volume":"21","author":"Mitsnefes","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2019070401125069200_sfz081-B47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpeds.2014.06.027","article-title":"Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure","volume":"165","author":"Ali","year":"2014","journal-title":"J Pediatr"},{"key":"2019070401125069200_sfz081-B48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.118.11060","article-title":"FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA Study","volume":"72","author":"Akhabue","year":"2018","journal-title":"Hypertension"},{"key":"2019070401125069200_sfz081-B49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000362251","article-title":"Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease","volume":"39","author":"Seifert","year":"2014","journal-title":"Am J Nephrol"},{"key":"2019070401125069200_sfz081-B50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000366169","article-title":"Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy","volume":"40","author":"Yilmaz","year":"2014","journal-title":"Am J Nephrol"},{"key":"2019070401125069200_sfz081-B51","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B52","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.2017121254","article-title":"A controlled increase in dietary phosphate elevates BP in healthy human subjects","volume":"29","author":"Mohammad","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2019070401125069200_sfz081-B53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ekir.2018.09.011","article-title":"Urinary extracellular vesicle protein profiling and endogenous lithium clearance support excessive renal sodium wasting and water reabsorption in thiazide-induced hyponatremia","volume":"4","author":"Channavajjhala","year":"2018","journal-title":"Kidney Int Rep"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfz081\/28901559\/sfz081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T21:48:26Z","timestamp":1663537706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article\/doi\/10.1093\/ckj\/sfz081\/5528005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfz081","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"type":"print","value":"2048-8505"},{"type":"electronic","value":"2048-8513"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"article-number":"sfz081"}}